Project Grant HT94252310525
Award Date 7/1/23
Completion Date 6/30/26
Dollars Obligated $1.3M
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Atlanta, GA 30322, USA
Similar Awards
- The Defense Health Agency awarded Emory University a $305,175 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to conduct research on a novel therapeutic target for renal medullary carcinoma. The award period runs from July 1, 2023 to June 30, 2026. As a leading research university, Emory has a strong track record of delivering scientific research and public health services under federal grants and contracts. This award supports Emory's expertise in...
- Emory University will conduct research under a $1,255,611 Project Grant from the Defense Health Agency through the Military Medical Research and Development program. The three-year award beginning in April 2023 will fund research to define the molecular basis for immunogenicity of locally advanced prostate tumors resistant to androgen deprivation therapy. The CFDA 12.420 program supports basic, applied and advanced biomedical research to transform military and public health care through...
- This Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) provides $187,800.00 to Emory University to conduct research on "Enhancing Radiosensitivity in CHD5-Depleted Lung Adenocarcinoma Through Inhibition of Nonhomologous End Joining (NHEJ)." The research project, which has a performance period from Mar 15, 2025 to Mar 14, 2026, aims to investigate innovative medical solutions for transforming healthcare for military...
- Federal Grant Award Summary Emory University's Office of Sponsored Programs received a $585,759 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective September 1, 2025 through August 31, 2028. The research project, "Targeting GPNMB to Improve Efficacy of CDK4/6 Inhibitors in ER+ Breast Cancer," will be conducted at Emory's Atlanta, Georgia campus. This three-year award supports advanced biomedical...
- The Defense Health Agency awarded Emory University a $156,500 project grant under the Military Medical Research and Development program to support research on core transcription factors in regenerative medicine and cancer. The one-year award beginning September 30, 2023 will fund investigation into medical solutions for the battlefield by transforming healthcare through innovative biomedical research. Specifically, Emory University will conduct research on core transcription factors as they...
- This Project Grant award from the Defense Health Agency provides $1,423,676 to Duke University from September 1, 2023 through August 31, 2026. The funding supports research targeting NUAK2 in neuroendocrine prostate cancer under the Military Medical Research and Development program (CFDA 12.420). The Military Medical Research and Development program aims to transform health care for service members and the public through innovative biomedical research. This award will further those goals by...
- Emory University was awarded a $586,875 Project Grant from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will fund research from September 1, 2023 to August 31, 2026 to elucidate and exploit SAMHD1 for breast cancer therapy. Through this funding, Emory University researchers will investigate medical solutions for breast cancer by exploring the role of the SAMHD1 protein and developing new therapeutic approaches for...
- Emory University was awarded a $586,875 Project Grant from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will fund research from September 1, 2023 to August 31, 2026 to elucidate and exploit SAMHD1 for breast cancer therapy. Through this funding, Emory University researchers will investigate medical solutions for breast cancer by exploring the role of the SAMHD1 protein and developing new therapeutic approaches for...
- The U.S. Defense Health Agency awarded a $1,449,000 Project Grant to Duke University to conduct research aimed at "Identifying Essential Molecular Mechanisms for Advanced Prostate Cancer Growth by a New Chemical Compound." This grant is funded under the Department of the Army Medical Command's Military Medical Research and Development program (CFDA 12.420), which supports biomedical research to improve the health and care of military service members, veterans, and their families. The...
- Emory University was awarded a $159,929 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant will fund whole-genome structural variation and CpG methylation analyses through long-read sequencing from April 1, 2023 to March 31, 2025. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research to transform military and public health care through innovative medical...